Peritoneal Carcinoma
📧 Sign up to get email alerts when something new happens for Peritoneal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial assessing feasibility and quality of life of second-look laparoscopy with hyperthermic intraperitoneal chemotherapy in ovarian…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors [Phase 1]
Phase 1 update reporting safety, pharmacokinetics, and preliminary efficacy data for AI-061 in advanced solid tumors across multiple indicat…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating genetically modified T cells in combination with decitabine for recurrent or refractory ovarian,…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the combination of Azenosertib (ZN-c3) and Niraparib in pl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with bevacizumab, with or without the anti-CD40 agonist CDX-1140, for recur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy [Phase 2]
Phase 2 trial evaluating a standardized AHCC extract in ovarian cancer patients on adjuvant chemotherapy; the study is currently active but …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: First in Human Study of IMGN151 in Recurrent Gynaecological Cancers [Phase 1]
This update covers the first-in-human Phase 1 study of IMGN151 in recurrent gynecologic cancers, sponsored by AbbVie, with the trial status …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy [NA]
Clinical trial update on prehabilitation care for women with advanced ovarian cancer undergoing neoadjuvant chemotherapy; the study is curre…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer [NA]
Clinical trial investigating whether hepato-celiac lymphadenectomy affects survival in primary or relapsed epithelial ovarian cancer and rel…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]
Phase 2 clinical trial update for I-131 Omburtamab in Desmoplastic Small Round Cell Tumor and other peritoneal cancers; the study is current…
-
CLINICAL_TRIALS other · 2025-05-15Clinical Trial Update: NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma [Phase 4]
Clinical trial status update for a Phase 4 study evaluating an NGS-based germline and somatic genetic test in ovarian carcinoma and related …
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating paclitaxel lipid suspension for platinum-resistant or refractory ovarian cancer and related platinum-res…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer [Phase 1]
A Phase 1 clinical trial of SCT-001 CAR T Cells Therapy for relapsed and refractory ovarian cancer and related peritoneal cancers is not yet…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial registry entry for a Phase 1/2a study of 23ME-00610 in patients with advanced solid malignancies, including several gynecolog…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors [EARLY_Phase 1]
An early-phase (Phase 1) trial is evaluating a dual-targeting CAR-T therapy against HER2 and PD-L1 for solid tumors, including metastatic pe…
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
The NCT01445275 trial on the cost of cancer risk management in women at elevated genetic risk for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinomatosis
This ClinicalTrials.gov entry notes an international registration to investigate the risk of serous peritoneal carcinomatosis associated wit…
-
CLINICAL_TRIALS trial_result · 2023-11-08Clinical Trial Update: Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) [Phase 3]
Phase 3 evaluation of adding AL3818 to standard platinum-based chemotherapy for recurrent or metastatic gynecologic carcinomas is in progres…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Phase 2, Phase 3]
Trial update for intraperitoneal therapy with carboplatin in epithelial ovarian cancer and related conditions; the study has completed phase…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy [Phase 3]
A Phase 3 trial evaluating high-dose inorganic selenium for preventing chemotherapy-induced peripheral neuropathy in ovarian cancer patients…